People · Operator
Named in public records as an officer, director or promoter · active 2009–2023 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Carterra, Inc. | — | Biotechnology | Series A | $34.5M | $34.5M | 2016 |
| NEXUS Biosystems, Inc. | — | Other Technology | Series A | $5.0M | $138.7M | 2009 |
John Lillig at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Lillig on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jack Ball | 1 | 10 |
| DEVAL LASHKARI | 1 | 6 |
| Jim Smith | 1 | 6 |
| Joe Keegan | 1 | 3 |
| Alexander Herzick | 1 | 3 |
| Gary Sams | 1 | 2 |
| GLENN NOVOTNY | 1 | 2 |
| Brenda Magill | 1 | 1 |
| Kirk Ririe | 1 | 1 |
| Josh Eckman | 1 | 1 |
| Bill Tew | 1 | 1 |
| Bruce Gale | 1 | 1 |
| Janel Fillinger | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.